ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads
Novo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers about treatment comparisons. Lilly denies wrongdoing and stands by its advertising claims. Both companies compete in
Announcement as on 24 July 2026

Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killer
India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disease. The approval follows a committee recommendation for adults with moderate to advanced liver fibrosis. Wegovy, cont
Announcement as on 17 July 2026

Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increase
Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients. Awiqli aims to reduce barriers to insulin initiation, which is often delayed
Announcement as on 09 July 2026

Shantha Biologics to make injectable drug cartridges for Novo Nordisk
Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable medicines at its Hyderabad facility. This partnership highlights India's growing role in advanced pharmaceutical man
Announcement as on 02 July 2026

Novo Nordisk A/S Q1 Earnings Call Highlights
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?Novo Nordisk A/S (NYSE:NVO) said its first quarter of 2026 was marked by rapid uptake of its newly launched Wegovy pill in the U.S., continued expansion of its obesity fr
Announcement as on 13 May 2026

Announcements by Novo Nordisk A/s first page | Next page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 48.66
  • 12Day Average: 49.43
  • 20Day Average: 49.26
  • 50Day Average: 46.37
  • 100Day Average: 43.13
  • 150Day Average: 46.05
  • 200Day Average: 47.11

NVO Indicators & signals

Indicator MACD (12,26,9)

49.01, 48.27, 1.08
Indicator MACD is in positive zone

Indicator ADX (14)

3.33, 20.81, 19.46
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 59
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Fri Jul 2026 48.77 47.78 to 49.52 0% 0.98 times
24 Fri Jul 2026 48.77 47.78 to 49.52 1.22% 0.98 times
23 Thu Jul 2026 48.18 47.23 to 48.93 -0.02% 0.97 times
22 Wed Jul 2026 48.19 47.98 to 49.64 -2.41% 1.03 times
21 Tue Jul 2026 49.38 48.95 to 49.91 -0.52% 0.69 times
20 Mon Jul 2026 49.64 49.56 to 50.50 -1.33% 0.84 times
17 Fri Jul 2026 50.31 50.00 to 51.77 -2.27% 1.16 times
16 Thu Jul 2026 51.48 50.55 to 51.77 1.84% 1.19 times
15 Wed Jul 2026 50.55 48.93 to 51.00 3% 1.29 times
14 Tue Jul 2026 49.08 48.29 to 49.49 -0.41% 0.66 times
13 Mon Jul 2026 49.28 48.76 to 49.67 -0.4% 1.19 times
10 Fri Jul 2026 49.48 48.73 to 49.64 1.25% 0.75 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top